Market Place
Sourcing Support
Immunex`s Biologic Enbrel(Etanercept) Receives Suppl Approval in US
22 Jul 2024 //
FDA
Samsung Bioepis` Eticovo (etanercept-ykro) Receives Suppl Approval in U.S.
03 May 2024 //
FDA
In lawsuit, Amgen slams Colorado`s proposed Enbrel price cap
27 Mar 2024 //
FIERCE PHARMA
Colorado begins process to set payment limit on Amgen`s arthritis drug Enbrel
26 Feb 2024 //
ENDPTS
Sandoz` Erelzi (etanercept) Receives Approval in Europe
14 Dec 2023 //
EMA
ImmuNext`s Biologic Enbrel (etanercept) Receives Approval in the U.S.
18 Oct 2023 //
FDA
Amgen dives deeper into rare disease drugs with $27.8 bln Horizon deal
13 Dec 2022 //
REUTERS
Sandoz`s Biologic Erelzi (Etanercept) Receives Approval in the U.S.
10 Nov 2022 //
FDA
Sandoz`s Biologic Erelzi (Etanercept) Receives Approval in the U.S.
10 Nov 2022 //
FDA
Immunex`s Biologic Enbrel (Etanercept) Receives Approval in the U.S.
16 Aug 2022 //
FDA
Pfizer sues to halt rival arthritis drug
10 May 2022 //
CRIKEY
Amgen has delayed the entry of another Enbrel biosimilar
02 Dec 2021 //
FIERCEPHARMA
NICE recommends several treatment options to help thousands with moderate RA
10 Jun 2021 //
NICE
Treating Juvenile Idiopathic Arthritis to Target Associated With Reduced Pain
10 Jun 2021 //
FIRSTWORLDPHARMA
Biogen Welcomes NICE Announcement on TA375 in Moderate Rheumatoid Arthritis
01 Jun 2021 //
GLOBENEWSWIRE
U.S. Supreme Court snubs Novartis appeal over arthritis drug Enbrel
19 May 2021 //
REUTERS
Sandoz`s Enbrel biosim case turned away at the Supreme Court
18 May 2021 //
FIERCE PHARMA
Health Canada approves Merck’s etanercept biosimilar for new indications
23 Sep 2020 //
BIGMOLECULEWATCH
Lupin, Mylan Launch Etanercept Biosimilar in Germany
27 Aug 2020 //
BIGMOLECULEWATCH
Sandoz Warns Federal Circuit Enbrel Ruling Invites Patent Abuse
04 Aug 2020 //
LAW360
Could Amgen test Enbrel or other anti-TNF drugs in COVID-19?
10 Jul 2020 //
FIERCE PHARMA
Amgen defeats Novartis appeal over arthritis drug Enbrel`s patents
03 Jul 2020 //
REUTERS
Amgen prevails in high-stakes drug case against Novartis
02 Jul 2020 //
BIOPHARMADIVE
Sandoz reviewing options after Federal Circuit upholds lower court Erelzi® case
01 Jul 2020 //
PRESS RELEASE
US appeals court upholds validity of Amgen`s Enbrel patents
01 Jul 2020 //
PRESS RELEASE
Ayumi Chief Says Contender Debut Will Add Vigor to Enbrel Biosimilar Space
23 Jun 2020 //
PHARMA JAPAN
Sandoz`s Erelzi (Etanercept Szzs) Receives Supplemental Approval in US
17 Jun 2020 //
FDA
Mylan and Lupin Receive European Marketing Authorization for Nepexto®
04 Jun 2020 //
PRNEWSWIRE
AryoGen’s bevacizumab biosimilar BE1040V found noninferior to AVASTIN
12 May 2020 //
BIGMOLECULEWATCH
UCB`s Cimzia is Making Inroads in the Treatment of Axial Disease
29 Apr 2020 //
PR NEWSWIRE
EMA committee recommends approval of Lupin & Mylan’s Nepexto, etanercept
30 Mar 2020 //
PHARMABIZ
Immunex`s Enbrel (Etanercept) Receives Approval in US
06 Mar 2020 //
FDA
Amgen favored to beat Novartis in Enbrel patent appeal: analyst
06 Mar 2020 //
FIERCE PHARMA
Clover Biopharma Initiates Ph III Study of Etanercept Biosimilar SCB-808
31 Dec 2019 //
BUSINESSWIRE
Clover Biopharmaceuticals Initiates Phase III Study of SCB-808 in China
30 Dec 2019 //
BUSINESSWIRE
After FTC surprises, pharma should expect more M&A scrutiny in 2020
21 Dec 2019 //
FIERCE PHARMA
Amgen and PBM Forge Outcomes-Based Agreement for Enbrel
05 Dec 2019 //
FIERCE PHARMA
Amgen to welcome Celgene’s Otezla reps, will they join?
28 Aug 2019 //
FIERCE PHARMA
Amgen`s overpayment for Otezla could pay off: analysts
28 Aug 2019 //
FIERCE PHARMA
Amgen to Buy Psoriasis Treatment Otezla for $13.4 Billion in Cash
27 Aug 2019 //
PRESS RELEASE
The key dates for KRAS watchers through the end of the year
16 Aug 2019 //
ENDPTS
The top 10 franchise drugs in biopharma history will earn $1.4T (trillion)
16 Aug 2019 //
ENDPTS
Amgen Wins Enbrel Patent Suit Preventing Sandoz Biosimilar Launch
13 Aug 2019 //
RAPS
Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis
09 Aug 2019 //
CNBC
Takeda, Pfizer terminate co-promotion of RA Drug Enbrel
30 Jul 2019 //
BIOSPECTRUMASIA
Pharma leaders: support the social contract on drug prices (STAT)
30 Jul 2019 //
STATNEWS
In a crowded psoriasis field, who could nab Celgene’s Otezla—and at what price?
02 Jul 2019 //
FIERCE PHARMA
The Washington Post points the finger at Pfizer for staying mum
05 Jun 2019 //
ENDPTS
Lupin receives EU GMP certificate for Mammalian facility in Pune
27 May 2019 //
FDA
And if They Don’t Dance, Well They’re No Friends of Mine & They’ll Get Sued
08 May 2019 //
FDALAWBLOG
Biotech Amgen reveals earnings beat in face of rising competition
01 May 2019 //
BARRONS
Samsung Bioepis Sued Regarding Its Recently-Approved Etanercept Biosimilar
30 Apr 2019 //
BIGMOLECULEWATCH
FDA Approves ETICOVO™, Samsung Bioepis` Second Anti-TNF Medicine
29 Apr 2019 //
BUSINESSWIRE
FDA Approves 19th Biosimilar, 2nd for Enbrel
27 Apr 2019 //
RAPS
Amgen`s postmenopausal osteoporosis drug gets FDA greenlight
11 Apr 2019 //
REUTERS
Lupin’s Etanercept Biosimilar Gains Approval in Japan
04 Apr 2019 //
BIOMOLECULEWATCH
Amgen`s top-selling Enbrel in balance as key court ruling nears
14 Mar 2019 //
BIOPHARMABIVE
Sun debuts first TV campaign for psoriasis entry Ilumya
11 Mar 2019 //
FIERCE PHARMA
